GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicell Inc (MEX:OMCL) » Definitions » Total Liabilities

Omnicell (MEX:OMCL) Total Liabilities : MXN18,304 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Omnicell Total Liabilities?

Omnicell's Total Liabilities for the quarter that ended in Dec. 2024 was MXN18,304 Mil.

Omnicell's quarterly Total Liabilities increased from Jun. 2024 (MXN19,947.83 Mil) to Sep. 2024 (MXN21,113.12 Mil) but then declined from Sep. 2024 (MXN21,113.12 Mil) to Dec. 2024 (MXN18,303.94 Mil).

Omnicell's annual Total Liabilities declined from Dec. 2022 (MXN21,067.79 Mil) to Dec. 2023 (MXN17,617.98 Mil) but then increased from Dec. 2023 (MXN17,617.98 Mil) to Dec. 2024 (MXN18,303.94 Mil).


Omnicell Total Liabilities Historical Data

The historical data trend for Omnicell's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicell Total Liabilities Chart

Omnicell Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,047.46 20,427.99 21,067.79 17,617.98 18,303.94

Omnicell Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,617.98 18,175.52 19,947.83 21,113.12 18,303.94

Omnicell Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Omnicell's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=12423.282+(4119.418+150.536
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+1610.707+0+0)
=18,304

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=44234.105-25930.163
=18,304

Omnicell's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=12423.282+(4119.418+150.536
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+1610.707+0+0)
=18,304

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=44234.105-25930.163
=18,304

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omnicell Total Liabilities Related Terms

Thank you for viewing the detailed overview of Omnicell's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnicell Business Description

Traded in Other Exchanges
Address
4220 North Freeway, Fort Worth, Santa Clara, CA, USA, 76137
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.